General Information


DRACP ID  DRACP06018

Peptide Name  

Sequence  XGFFYKD

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Targeted peptide conjugates



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Lonidamine

Chiral  L



Physicochemical Information


Formula  C39H47N7O9

Absent amino acids  ACEHILMNPQRSTVW

Common amino acids  F

Mass  97504

Pl  6.34

Basic residues  1

Acidic residues  1

Hydrophobic residues  2

Net charge  0

Boman Index  -751

Hydrophobicity  -50

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  248.33

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN114159581A

Patent Title  Polypeptide hydrogel and application thereof in preparation of tumor treatment medicine

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.